What makes this parasomnia so frightening?
Groundbreaking science and cross-specialty collaboration enable transplant recipients to thrive without immunosuppressive drugs
‘It is a recognition of the scholarly environment and infrastructure we have built to enable and foster outstanding scientific research,’ says David Geffen School of Medicine Dean Kelsey Martin
Laurie Adami participated in the trial for the immunotherapy treatment, which received FDA approval March 5
Parton knew he needed extraordinary measures to beat the disease: the cancer was spreading all over his body. That’s when he met with Dr. Edward Garon of the UCLA's Jonsson Comprehensive Cancer Center